Geneseeq

About:

Geneseeq uses NGS technologies to help physicians make meaningful decisions for cancer treatment.

Website: https://na.geneseeq.com

Twitter/X: GeneseeqInc

Top Investors: Lilly Asia Ventures, Cowin Capital, Huatai Securities, SBCVC, Industrial Securities Capital

Description:

Established in 2008, Geneseeq is an industry leader in Next-Generation Sequencing (NGS) fully committed to the research and clinical translation of NGS Genetic Sequencing in the field of personalized medicine. Geneseeq’s world-leading laboratories have successfully passed China’s National Center of Clinical Laboratories(NCCL) External Quality Assessment(EQA), College of American Pathologists(CAP) PT, European Molecular Genetics Quality Network(EMQN) PT, and received 3rd party medical laboratory and clinical PCR amplification laboratory qualifications.